{"metadata":{"kernelspec":{"name":"python3","display_name":"Python 3","language":"python"},"language_info":{"name":"python","version":"3.11.13","mimetype":"text/x-python","codemirror_mode":{"name":"ipython","version":3},"pygments_lexer":"ipython3","nbconvert_exporter":"python","file_extension":".py"},"kaggle":{"accelerator":"none","dataSources":[],"isInternetEnabled":true,"language":"python","sourceType":"notebook","isGpuEnabled":false}},"nbformat_minor":4,"nbformat":4,"cells":[{"cell_type":"code","source":"import os\nfrom kaggle_secrets import UserSecretsClient\n\ntry:\n    GOOGLE_API_KEY = UserSecretsClient().get_secret(\"GOOGLE_API_KEY\")\n    os.environ[\"GOOGLE_API_KEY\"] = GOOGLE_API_KEY\n    print(\"âœ… Gemini API key setup complete.\")\nexcept Exception as e:\n    print(\n        f\"ðŸ”‘ Authentication Error: Please make sure you have added 'GOOGLE_API_KEY' to your Kaggle secrets. Details: {e}\"\n    )","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T12:43:40.668185Z","iopub.execute_input":"2025-11-14T12:43:40.668482Z","iopub.status.idle":"2025-11-14T12:43:40.827185Z","shell.execute_reply.started":"2025-11-14T12:43:40.668431Z","shell.execute_reply":"2025-11-14T12:43:40.826233Z"}},"outputs":[{"name":"stdout","text":"âœ… Gemini API key setup complete.\n","output_type":"stream"}],"execution_count":1},{"cell_type":"code","source":"from typing import Any, Dict\n\nfrom google.adk.agents import Agent, LlmAgent\nfrom google.adk.apps.app import App, EventsCompactionConfig\nfrom google.adk.models.google_llm import Gemini\nfrom google.adk.sessions import DatabaseSessionService\nfrom google.adk.sessions import InMemorySessionService\nfrom google.adk.runners import Runner\nfrom google.adk.tools.tool_context import ToolContext\nfrom google.genai import types\n\nprint(\"âœ… ADK components imported successfully.\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T12:44:01.348929Z","iopub.execute_input":"2025-11-14T12:44:01.349234Z","iopub.status.idle":"2025-11-14T12:44:42.968395Z","shell.execute_reply.started":"2025-11-14T12:44:01.349212Z","shell.execute_reply":"2025-11-14T12:44:42.967401Z"}},"outputs":[{"name":"stdout","text":"âœ… ADK components imported successfully.\n","output_type":"stream"}],"execution_count":2},{"cell_type":"code","source":"# Define helper functions that will be reused throughout the notebook\nasync def run_session(\n    runner_instance: Runner,\n    user_queries: list[str] | str = None,\n    session_name: str = \"default\",\n):\n    print(f\"\\n ### Session: {session_name}\")\n\n    # Get app name from the Runner\n    app_name = runner_instance.app_name\n\n    # Attempt to create a new session or retrieve an existing one\n    try:\n        session = await session_service.create_session(\n            app_name=app_name, user_id=USER_ID, session_id=session_name\n        )\n    except:\n        session = await session_service.get_session(\n            app_name=app_name, user_id=USER_ID, session_id=session_name\n        )\n\n    # Process queries if provided\n    if user_queries:\n        # Convert single query to list for uniform processing\n        if type(user_queries) == str:\n            user_queries = [user_queries]\n\n        # Process each query in the list sequentially\n        for query in user_queries:\n            print(f\"\\nUser > {query}\")\n\n            # Convert the query string to the ADK Content format\n            query = types.Content(role=\"user\", parts=[types.Part(text=query)])\n\n            # Stream the agent's response asynchronously\n            async for event in runner_instance.run_async(\n                user_id=USER_ID, session_id=session.id, new_message=query\n            ):\n                # Check if the event contains valid content\n                if event.content and event.content.parts:\n                    # Filter out empty or \"None\" responses before printing\n                    if (\n                        event.content.parts[0].text != \"None\"\n                        and event.content.parts[0].text\n                    ):\n                        print(f\"{MODEL_NAME} > \", event.content.parts[0].text)\n    else:\n        print(\"No queries!\")\n\n\nprint(\"âœ… Helper functions defined.\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T12:50:22.441392Z","iopub.execute_input":"2025-11-14T12:50:22.443275Z","iopub.status.idle":"2025-11-14T12:50:22.452937Z","shell.execute_reply.started":"2025-11-14T12:50:22.443244Z","shell.execute_reply":"2025-11-14T12:50:22.451902Z"}},"outputs":[{"name":"stdout","text":"âœ… Helper functions defined.\n","output_type":"stream"}],"execution_count":3},{"cell_type":"code","source":"retry_config = types.HttpRetryOptions(\n    attempts=5,  # Maximum retry attempts\n    exp_base=7,  # Delay multiplier\n    initial_delay=1,\n    http_status_codes=[429, 500, 503, 504],  # Retry on these HTTP errors\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T12:50:41.111521Z","iopub.execute_input":"2025-11-14T12:50:41.111895Z","iopub.status.idle":"2025-11-14T12:50:41.116551Z","shell.execute_reply.started":"2025-11-14T12:50:41.111858Z","shell.execute_reply":"2025-11-14T12:50:41.115656Z"}},"outputs":[],"execution_count":4},{"cell_type":"code","source":"APP_NAME = \"default\"  # Application\nUSER_ID = \"default\"  # User\nSESSION = \"default\"  # Session\n\nMODEL_NAME = \"gemini-2.5-flash-lite\"\n\n\n# Step 1: Create the LLM Agent\nroot_agent = Agent(\n    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n    name=\"text_chat_bot\",\n    description=\"A text chatbot\",  # Description of the agent's purpose\n)\n\n# Step 2: Set up Session Management\n# InMemorySessionService stores conversations in RAM (temporary)\nsession_service = InMemorySessionService()\n\n# Step 3: Create the Runner\nrunner = Runner(agent=root_agent, app_name=APP_NAME, session_service=session_service)\n\nprint(\"âœ… Stateful agent initialized!\")\nprint(f\"   - Application: {APP_NAME}\")\nprint(f\"   - User: {USER_ID}\")\nprint(f\"   - Using: {session_service.__class__.__name__}\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T12:51:15.933158Z","iopub.execute_input":"2025-11-14T12:51:15.933509Z","iopub.status.idle":"2025-11-14T12:51:15.941733Z","shell.execute_reply.started":"2025-11-14T12:51:15.933482Z","shell.execute_reply":"2025-11-14T12:51:15.940782Z"}},"outputs":[{"name":"stdout","text":"âœ… Stateful agent initialized!\n   - Application: default\n   - User: default\n   - Using: InMemorySessionService\n","output_type":"stream"}],"execution_count":5},{"cell_type":"code","source":"# Run a conversation with two queries in the same session\n# Notice: Both queries are part of the SAME session, so context is maintained\nawait run_session(\n    runner,\n    [\n        \"Hi, I am Sam! What is the capital of United States?\",\n        \"Hello! What is my name?\",  # This time, the agent should remember!\n    ],\n    \"stateful-agentic-session\",\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T12:51:44.963155Z","iopub.execute_input":"2025-11-14T12:51:44.963852Z","iopub.status.idle":"2025-11-14T12:51:46.487399Z","shell.execute_reply.started":"2025-11-14T12:51:44.963811Z","shell.execute_reply":"2025-11-14T12:51:46.486472Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: stateful-agentic-session\n\nUser > Hi, I am Sam! What is the capital of United States?\ngemini-2.5-flash-lite >  Hi Sam! The capital of the United States is Washington, D.C.\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  Your name is Sam.\n","output_type":"stream"}],"execution_count":6},{"cell_type":"code","source":"# Run this cell after restarting the kernel. All this history will be gone...\nawait run_session(\n    runner,\n    [\"What did I ask you about earlier?\", \"And remind me, what's my name?\"],\n    \"stateful-agentic-session\",\n)  # Note, we are using same session name","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T12:53:43.723228Z","iopub.execute_input":"2025-11-14T12:53:43.723607Z","iopub.status.idle":"2025-11-14T12:53:44.647784Z","shell.execute_reply.started":"2025-11-14T12:53:43.723582Z","shell.execute_reply":"2025-11-14T12:53:44.646851Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: stateful-agentic-session\n\nUser > What did I ask you about earlier?\ngemini-2.5-flash-lite >  You asked me about the capital of the United States.\n\nUser > And remind me, what's my name?\ngemini-2.5-flash-lite >  Your name is Sam.\n","output_type":"stream"}],"execution_count":7},{"cell_type":"code","source":"# Step 1: Create the same agent (notice we use LlmAgent this time)\nchatbot_agent = LlmAgent(\n    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n    name=\"text_chat_bot\",\n    description=\"A text chatbot with persistent memory\",\n)\n\n# Step 2: Switch to DatabaseSessionService\n# SQLite database will be created automatically\ndb_url = \"sqlite:///my_agent_data.db\"  # Local SQLite file\nsession_service = DatabaseSessionService(db_url=db_url)\n\n# Step 3: Create a new runner with persistent storage\nrunner = Runner(agent=chatbot_agent, app_name=APP_NAME, session_service=session_service)\n\nprint(\"âœ… Upgraded to persistent sessions!\")\nprint(f\"   - Database: my_agent_data.db\")\nprint(f\"   - Sessions will survive restarts!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T12:55:09.308453Z","iopub.execute_input":"2025-11-14T12:55:09.308816Z","iopub.status.idle":"2025-11-14T12:55:09.414533Z","shell.execute_reply.started":"2025-11-14T12:55:09.308790Z","shell.execute_reply":"2025-11-14T12:55:09.413522Z"}},"outputs":[{"name":"stdout","text":"âœ… Upgraded to persistent sessions!\n   - Database: my_agent_data.db\n   - Sessions will survive restarts!\n","output_type":"stream"}],"execution_count":8},{"cell_type":"code","source":"await run_session(\n    runner,\n    [\"Hi, I am Sam! What is the capital of the United States?\", \"Hello! What is my name?\"],\n    \"test-db-session-01\",\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T12:55:22.668587Z","iopub.execute_input":"2025-11-14T12:55:22.669423Z","iopub.status.idle":"2025-11-14T12:55:23.681678Z","shell.execute_reply.started":"2025-11-14T12:55:22.669383Z","shell.execute_reply":"2025-11-14T12:55:23.680671Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: test-db-session-01\n\nUser > Hi, I am Sam! What is the capital of the United States?\ngemini-2.5-flash-lite >  Hello Sam! The capital of the United States is Washington, D.C.\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  You told me your name is Sam!\n","output_type":"stream"}],"execution_count":9},{"cell_type":"code","source":"await run_session(\n    runner,\n    [\"What is the capital of India?\", \"Hello! What is my name?\"],\n    \"test-db-session-01\",\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T12:59:32.080882Z","iopub.execute_input":"2025-11-14T12:59:32.081489Z","iopub.status.idle":"2025-11-14T12:59:33.593860Z","shell.execute_reply.started":"2025-11-14T12:59:32.081465Z","shell.execute_reply":"2025-11-14T12:59:33.593029Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: test-db-session-01\n\nUser > What is the capital of India?\ngemini-2.5-flash-lite >  The capital of India is New Delhi.\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  Your name is Sam.\n","output_type":"stream"}],"execution_count":10},{"cell_type":"code","source":"await run_session(\n    runner, [\"Hello! What is my name?\"], \"test-db-session-02\"\n)  # Note, we are using new session name","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T12:59:52.855677Z","iopub.execute_input":"2025-11-14T12:59:52.856678Z","iopub.status.idle":"2025-11-14T12:59:53.304635Z","shell.execute_reply.started":"2025-11-14T12:59:52.856637Z","shell.execute_reply":"2025-11-14T12:59:53.303763Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: test-db-session-02\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  I do not have access to your personal information, including your name. Therefore, I cannot tell you what your name is.\n","output_type":"stream"}],"execution_count":11},{"cell_type":"code","source":"import sqlite3\n\ndef check_data_in_db():\n    with sqlite3.connect(\"my_agent_data.db\") as connection:\n        cursor = connection.cursor()\n        result = cursor.execute(\n            \"select app_name, session_id, author, content from events\"\n        )\n        print([_[0] for _ in result.description])\n        for each in result.fetchall():\n            print(each)\n\n\ncheck_data_in_db()","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T13:00:08.633432Z","iopub.execute_input":"2025-11-14T13:00:08.633724Z","iopub.status.idle":"2025-11-14T13:00:08.640497Z","shell.execute_reply.started":"2025-11-14T13:00:08.633681Z","shell.execute_reply":"2025-11-14T13:00:08.639571Z"}},"outputs":[{"name":"stdout","text":"['app_name', 'session_id', 'author', 'content']\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hi, I am Sam! What is the capital of the United States?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Hello Sam! The capital of the United States is Washington, D.C.\"}], \"role\": \"model\"}')\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"You told me your name is Sam!\"}], \"role\": \"model\"}')\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"What is the capital of India?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"The capital of India is New Delhi.\"}], \"role\": \"model\"}')\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Your name is Sam.\"}], \"role\": \"model\"}')\n('default', 'test-db-session-02', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-02', 'text_chat_bot', '{\"parts\": [{\"text\": \"I do not have access to your personal information, including your name. Therefore, I cannot tell you what your name is.\"}], \"role\": \"model\"}')\n","output_type":"stream"}],"execution_count":12},{"cell_type":"code","source":"# Re-define our app with Events Compaction enabled\nresearch_app_compacting = App(\n    name=\"research_app_compacting\",\n    root_agent=chatbot_agent,\n    # This is the new part!\n    events_compaction_config=EventsCompactionConfig(\n        compaction_interval=3,  # Trigger compaction every 3 invocations\n        overlap_size=1,  # Keep 1 previous turn for context\n    ),\n)\n\ndb_url = \"sqlite:///my_agent_data.db\"  # Local SQLite file\nsession_service = DatabaseSessionService(db_url=db_url)\n\n# Create a new runner for our upgraded app\nresearch_runner_compacting = Runner(\n    app=research_app_compacting, session_service=session_service\n)\n\n\nprint(\"âœ… Research App upgraded with Events Compaction!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T13:00:43.058594Z","iopub.execute_input":"2025-11-14T13:00:43.058945Z","iopub.status.idle":"2025-11-14T13:00:43.068233Z","shell.execute_reply.started":"2025-11-14T13:00:43.058920Z","shell.execute_reply":"2025-11-14T13:00:43.067214Z"}},"outputs":[{"name":"stdout","text":"âœ… Research App upgraded with Events Compaction!\n","output_type":"stream"},{"name":"stderr","text":"/tmp/ipykernel_48/3773147741.py:6: UserWarning: [EXPERIMENTAL] EventsCompactionConfig: This feature is experimental and may change or be removed in future versions without notice. It may introduce breaking changes at any time.\n  events_compaction_config=EventsCompactionConfig(\n","output_type":"stream"}],"execution_count":13},{"cell_type":"code","source":"# Turn 1\nawait run_session(\n    research_runner_compacting,\n    \"What is the latest news about AI in healthcare?\",\n    \"compaction_demo\",\n)\n\n# Turn 2\nawait run_session(\n    research_runner_compacting,\n    \"Are there any new developments in drug discovery?\",\n    \"compaction_demo\",\n)\n\n# Turn 3 - Compaction should trigger after this turn!\nawait run_session(\n    research_runner_compacting,\n    \"Tell me more about the second development you found.\",\n    \"compaction_demo\",\n)\n\n# Turn 4\nawait run_session(\n    research_runner_compacting,\n    \"Who are the main companies involved in that?\",\n    \"compaction_demo\",\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T13:01:02.493644Z","iopub.execute_input":"2025-11-14T13:01:02.494612Z","iopub.status.idle":"2025-11-14T13:01:20.761353Z","shell.execute_reply.started":"2025-11-14T13:01:02.494582Z","shell.execute_reply":"2025-11-14T13:01:20.760284Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: compaction_demo\n\nUser > What is the latest news about AI in healthcare?\ngemini-2.5-flash-lite >  There's a lot of exciting news in AI in healthcare! Here's a rundown of some of the key trends and recent developments:\n\n**1. Diagnostics and Imaging:**\n\n*   **Accelerated Drug Discovery:** AI is significantly speeding up the process of identifying potential drug candidates and predicting their efficacy. This is a major area of investment and research.\n*   **Personalized Medicine:** AI is helping to analyze vast amounts of patient data (genomics, medical history, lifestyle) to tailor treatments and preventative strategies to individual needs.\n*   **Predictive Analytics for Disease Outbreaks:** AI models are being developed to predict and track the spread of infectious diseases, allowing for earlier interventions and better resource allocation.\n\n**2. AI-Powered Tools and Applications:**\n\n*   **Diagnostic Support:** AI algorithms are getting increasingly sophisticated at analyzing medical images (X-rays, CT scans, MRIs, pathology slides) to detect abnormalities like tumors, diabetic retinopathy, and cardiovascular issues, often with accuracy comparable to or exceeding human experts.\n*   **Robotic Surgery:** AI is enhancing robotic surgical systems, offering greater precision, enabling minimally invasive procedures, and assisting surgeons with real-time guidance.\n*   **Virtual Assistants and Chatbots:** AI-powered chatbots are being used for patient triage, answering common health questions, scheduling appointments, and providing remote patient monitoring.\n*   **Administrative Efficiency:** AI is being deployed to automate administrative tasks like medical coding, billing, claims processing, and managing electronic health records (EHRs), freeing up healthcare professionals' time.\n*   **Mental Health Support:** AI is being used to develop tools for early detection of mental health conditions, personalized therapy recommendations, and even AI-powered companions for support.\n\n**3. Key Themes and Challenges:**\n\n*   **Data Privacy and Security:** With the increasing use of sensitive patient data, ensuring robust privacy and security measures is paramount.\n*   **Regulatory Approval:** Navigating the regulatory landscape (like FDA approval in the US) for AI-powered medical devices and software is a crucial step for widespread adoption.\n*   **Ethical Considerations:** Issues of bias in AI algorithms, accountability for AI-driven decisions, and the potential impact on the patient-physician relationship are ongoing discussions.\n*   **Integration into Clinical Workflows:** Seamlessly integrating AI tools into existing healthcare systems and workflows is a significant challenge.\n*   **Explainability and Trust:** Developing AI models that can explain their reasoning (explainable AI or XAI) is important for building trust among clinicians and patients.\n\n**Recent Examples and Trends to Watch:**\n\n*   **Generative AI in Healthcare:** Beyond text generation, generative AI is being explored for creating synthetic medical data for training purposes, designing novel protein structures for drug development, and even generating personalized patient education materials.\n*   **AI for Rare Diseases:** AI is proving valuable in identifying patterns in patient data that might indicate rare diseases, which are often difficult to diagnose.\n*   **Focus on Underserved Populations:** Efforts are underway to ensure AI solutions are developed and deployed in ways that benefit all populations, addressing existing healthcare disparities.\n\nTo get the absolute latest news, I'd recommend checking out reputable sources like:\n\n*   **Major medical journals:** JAMA, The Lancet, NEJM\n*   **Healthcare technology news outlets:** FierceBiotech, Healthcare IT News, MobiHealthNews\n*   **Reputable AI research institutions and companies**\n\nThe field is evolving rapidly, so keep an eye out for breakthroughs in these areas!\n\n ### Session: compaction_demo\n\nUser > Are there any new developments in drug discovery?\ngemini-2.5-flash-lite >  Yes, absolutely! Drug discovery is one of the areas where AI is having the most profound and rapid impact. Here are some of the key new developments:\n\n**1. Generative AI for Molecule Design:**\n\n*   **Novel Molecule Generation:** Instead of just screening existing libraries of compounds, generative AI models can now **design entirely new molecules** from scratch with desired properties. This includes generating molecules that are predicted to be highly effective against a specific target, have good pharmacokinetic profiles (how the body absorbs, distributes, metabolizes, and excretes a drug), and minimize toxicity.\n*   **De Novo Design Platforms:** Companies are developing sophisticated platforms that use generative AI to explore vast chemical spaces, proposing novel drug candidates that human chemists might not have conceived.\n\n**2. Accelerating Target Identification and Validation:**\n\n*   **Multi-omics Integration:** AI is becoming increasingly adept at integrating and analyzing diverse biological datasets, including genomics, proteomics, transcriptomics, and metabolomics. This allows researchers to identify novel disease targets and understand the complex biological pathways involved in diseases more comprehensively.\n*   **Predicting Target Druggability:** AI models can now help predict whether a newly identified target is likely to be \"druggable\" â€“ meaning that a molecule can be designed to interact with it effectively.\n\n**3. Improving Preclinical Testing:**\n\n*   **In Silico Screening and Prediction:** AI can dramatically speed up the initial screening of potential drug candidates by performing virtual experiments. This includes predicting a molecule's binding affinity to a target, its potential side effects, and its ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicity) properties **before** expensive and time-consuming lab experiments are conducted.\n*   **Predicting Clinical Trial Success:** AI is being used to analyze historical clinical trial data and identify factors that correlate with success or failure. This can help optimize trial design and predict the likelihood of a drug candidate progressing through clinical trials.\n*   **Reducing Animal Testing:** By providing more accurate in silico predictions, AI can potentially reduce the number of animal tests required in preclinical stages.\n\n**4. Repurposing Existing Drugs:**\n\n*   **Network Pharmacology:** AI can analyze complex biological networks to identify existing drugs that might be effective against new diseases or different disease mechanisms. This is a faster and often less risky approach than developing entirely new drugs.\n\n**5. Enhancing Clinical Trial Design and Execution:**\n\n*   **Patient Stratification:** AI can identify specific patient subgroups who are most likely to respond to a particular drug, leading to more efficient and successful clinical trials.\n*   **Biomarker Discovery:** AI can help discover new biomarkers that can be used to monitor drug efficacy and patient response during clinical trials.\n*   **Optimizing Trial Operations:** AI can assist with site selection, patient recruitment, and data monitoring for clinical trials.\n\n**Key Players and Technologies:**\n\n*   **AI-first Drug Discovery Companies:** Companies like **Recursion Pharmaceuticals, Insilico Medicine, Exscientia, BenevolentAI, and Atomwise** are at the forefront, leveraging AI to build their drug pipelines.\n*   **Large Pharmaceutical Companies:** Major pharma players are heavily investing in and partnering with AI companies to integrate these technologies into their R&D processes.\n*   **Machine Learning Algorithms:** Deep learning, graph neural networks (GNNs), and reinforcement learning are among the key AI techniques being applied.\n\n**Challenges and Future Outlook:**\n\nDespite the rapid progress, challenges remain. These include the need for high-quality, curated data, the complexity of biological systems, and the regulatory hurdles. However, the trend is clear: AI is revolutionizing drug discovery, making it faster, more efficient, and potentially more successful in bringing much-needed new therapies to patients.\n\nIn essence, AI is moving drug discovery from a process of trial-and-error to one of highly informed design and prediction.\n\n ### Session: compaction_demo\n\nUser > Tell me more about the second development you found.\ngemini-2.5-flash-lite >  You're asking about the **\"Accelerated Drug Discovery\"** development I mentioned! This is a really broad and exciting area where AI is making a massive difference. Let's dive deeper into what that entails.\n\nWhen we talk about \"accelerated drug discovery\" using AI, it's about **speeding up and improving the efficiency of virtually every stage of the drug development pipeline**. Traditionally, discovering and bringing a new drug to market can take over a decade and cost billions of dollars, with a very high failure rate. AI is changing this by optimizing key processes.\n\nHere's a breakdown of how AI is accelerating drug discovery:\n\n**1. Target Identification and Validation: Finding the \"Why\" and \"What\" of a Disease**\n\n*   **What it is:** Before you can develop a drug, you need to understand what biological target (like a specific protein or gene) is involved in a disease and whether modulating that target could have a therapeutic effect.\n*   **How AI accelerates it:**\n    *   **Analyzing Vast Datasets:** AI can sift through massive amounts of genomic, proteomic, transcriptomic, and clinical data from public databases and internal company research far faster than humans. It can identify subtle patterns and correlations that might point to novel disease targets.\n    *   **Predicting Target Druggability:** Not all targets are \"druggable.\" AI models can predict, based on structural information and known drug-target interactions, whether a target is likely to bind to a drug molecule and whether that interaction is likely to be therapeutically beneficial. This saves significant time and resources by prioritizing targets that have a higher chance of success.\n    *   **Uncovering Complex Disease Mechanisms:** Many diseases are not caused by a single factor. AI can help unravel intricate biological pathways and interactions, revealing more nuanced and effective targets that might have been missed by traditional methods.\n\n**2. Hit Identification and Lead Optimization: Finding and Refining the \"Right\" Molecule**\n\n*   **What it is:** Once a target is identified, researchers need to find molecules (called \"hits\") that interact with it. These hits are then optimized to become \"leads\" with better potency, selectivity, and safety profiles.\n*   **How AI accelerates it:**\n    *   **Virtual Screening (In Silico Screening):** Instead of physically testing millions of compounds in the lab, AI can simulate the interaction of vast virtual libraries of molecules with the target. This drastically reduces the number of compounds that need to be synthesized and experimentally tested, saving immense time and cost.\n    *   **Generative AI for De Novo Design:** As I mentioned before, AI can now *design* new molecules from scratch that are predicted to have specific desired properties. This moves beyond just finding existing compounds and allows for the creation of truly novel drug candidates tailored to a target.\n    *   **Predicting Molecular Properties:** AI models can predict various properties of a molecule, such as its binding affinity, solubility, stability, and potential toxicity, with remarkable accuracy. This allows researchers to quickly filter out less promising candidates and focus on those with the best chance of success.\n    *   **Structure-Activity Relationship (SAR) Modeling:** AI can learn complex relationships between a molecule's structure and its biological activity, guiding chemists on how to modify existing leads to improve their efficacy and safety.\n\n**3. Preclinical and Clinical Development: Moving Towards Patients**\n\n*   **What it is:** Once a lead compound is promising, it undergoes extensive preclinical testing (in labs and animals) and then clinical trials in humans.\n*   **How AI accelerates it:**\n    *   **Predicting ADMET Properties:** AI can predict how a drug will be absorbed, distributed, metabolized, excreted, and its potential toxicity in the body. This allows for early identification of potential problems that could lead to trial failure, saving significant time and resources.\n    *   **Biomarker Discovery:** AI can identify biomarkers that indicate whether a patient is likely to respond to a particular drug, or if the drug is having the desired effect. This is crucial for designing more efficient clinical trials and for precision medicine.\n    *   **Optimizing Clinical Trial Design:** AI can analyze historical clinical trial data to identify factors that correlate with success or failure, helping to design trials that are more likely to yield meaningful results. It can also help with patient recruitment by identifying suitable candidates based on their electronic health records.\n    *   **Predicting Trial Outcomes:** While still an evolving area, AI models are being developed to predict the likelihood of success for a clinical trial based on preclinical data and trial design.\n\n**In summary, AI accelerates drug discovery by:**\n\n*   **Reducing the time spent on manual tasks:** Automating data analysis and screening.\n*   **Improving the accuracy of predictions:** Leading to fewer failed experiments and trials.\n*   **Expanding the search space:** Enabling the discovery of novel molecules and targets.\n*   **Focusing resources on the most promising candidates:** Preventing wasted investment.\n\nThis acceleration is not just about speed; it's about making the entire process more intelligent, data-driven, and ultimately, more likely to deliver life-saving medicines to patients faster.\n\n ### Session: compaction_demo\n\nUser > Who are the main companies involved in that?\ngemini-2.5-flash-lite >  The landscape of companies involved in AI-driven drug discovery is dynamic and includes a mix of established pharmaceutical giants, nimble AI-first biotech startups, and specialized technology providers. Here's a breakdown of the main players and categories:\n\n**1. AI-First Drug Discovery Companies (The Innovators):**\n\nThese companies were built from the ground up with AI at their core, often focusing on proprietary AI platforms and algorithms to design and develop their own drug pipelines.\n\n*   **Recursion Pharmaceuticals:** Known for its \"Operating System for Biology\" which uses AI and automation to analyze vast amounts of cellular imagery and discover new drug targets and therapies.\n*   **Insilico Medicine:** A leader in generative AI for drug discovery. They have publicly showcased AI-designed drugs that have entered clinical trials relatively quickly. They focus on de novo molecule design and target identification.\n*   **Exscientia:** Employs AI to design drug candidates. They were one of the first to have an AI-designed drug enter clinical trials and have multiple AI-designed molecules in development across various therapeutic areas.\n*   **BenevolentAI:** Uses its AI platform to analyze scientific literature, patents, and clinical trial data to identify novel drug targets and discover potential treatments, particularly for rare diseases.\n*   **Atomwise:** Specializes in using deep learning for structure-based drug discovery. Their AtomNet platform predicts how small molecules will bind to proteins.\n*   **Relay Therapeutics:** Focuses on using structural biology and AI to understand protein motion and design drugs that precisely target these dynamic processes.\n*   **SchrÃ¶dinger:** While not exclusively AI-first, SchrÃ¶dinger has a long history in computational chemistry and physics-based modeling, and they are increasingly integrating AI and machine learning into their platforms for drug design and discovery.\n\n**2. Large Pharmaceutical Companies (The Adopters and Collaborators):**\n\nMajor pharmaceutical companies are actively integrating AI into their existing R&D operations. Many also engage in significant partnerships and acquisitions with AI-first companies.\n\n*   **Pfizer:** Has been investing in AI for drug discovery, including collaborations and internal initiatives.\n*   **Novartis:** Actively uses AI across its R&D, from target identification to clinical trial optimization. They have established AI innovation labs.\n*   **Roche/Genentech:** A strong player in genomics and data-driven research, they are leveraging AI for drug discovery and development, particularly in areas like oncology.\n*   **Merck (MSD):** Engages in AI initiatives, including collaborations and the development of AI tools for various stages of drug discovery.\n*   **AstraZeneca:** Has been a significant adopter of AI, using it for target identification, drug design, and clinical trial optimization.\n*   **Johnson & Johnson:** Utilizes AI in its pharmaceutical segment for drug discovery, development, and even in its medical device and consumer health divisions.\n*   **Bristol Myers Squibb:** Actively exploring AI and machine learning to accelerate its R&D efforts.\n\n**3. Technology and AI Platform Providers (The Enablers):**\n\nThese companies provide the underlying AI technologies, cloud infrastructure, and specialized software that power drug discovery efforts.\n\n*   **NVIDIA:** Their powerful GPUs and AI software platforms (like Clara Discovery) are critical for training complex AI models used in drug discovery, especially for simulations and molecular modeling.\n*   **Google (Verily/DeepMind):** While Verily is more broadly focused on life sciences, DeepMind's work on protein folding with AlphaFold has revolutionized structural biology, a key component of drug discovery. Google Cloud also offers AI/ML services for life sciences.\n*   **Microsoft (Azure for Healthcare):** Provides cloud infrastructure and AI tools that enable life sciences companies to build and deploy their AI solutions.\n*   **Amazon Web Services (AWS):** Similar to Microsoft, AWS offers extensive cloud computing and AI/ML services vital for handling large datasets and complex computations.\n\n**4. Contract Research Organizations (CROs) and Service Providers:**\n\nMany CROs are also building AI capabilities to offer accelerated services to their pharma clients.\n\n*   **IQVIA:** A major player in healthcare data and analytics, IQVIA is increasingly incorporating AI into its R&D services.\n*   **Labcorp Drug Development (formerly Covance):** Offers a range of drug development services and is integrating AI into its offerings.\n\n**Key Trends in Company Involvement:**\n\n*   **Partnerships and Acquisitions:** Large pharma companies are increasingly partnering with or acquiring AI-native biotech firms to gain access to their technology and talent.\n*   **In-house AI Development:** Many large pharma companies are building their own internal AI/ML teams and capabilities.\n*   **Focus on Specific Modalities:** Some AI companies are specializing in specific drug modalities, like small molecules, biologics, or even cell and gene therapies.\n*   **\"AI as a Service\":** The rise of specialized AI platforms that can be licensed or accessed on a service basis.\n\nThis list is not exhaustive, as the field is constantly evolving, with new companies emerging and existing ones expanding their AI focus. The collaboration between AI specialists and traditional pharmaceutical expertise is a defining characteristic of this revolution in drug discovery.\n","output_type":"stream"}],"execution_count":14},{"cell_type":"code","source":"# Get the final session state\nfinal_session = await session_service.get_session(\n    app_name=research_runner_compacting.app_name,\n    user_id=USER_ID,\n    session_id=\"compaction_demo\",\n)\n\nprint(\"--- Searching for Compaction Summary Event ---\")\nfound_summary = False\nfor event in final_session.events:\n    # Compaction events have a 'compaction' attribute\n    if event.actions and event.actions.compaction:\n        print(\"\\nâœ… SUCCESS! Found the Compaction Event:\")\n        print(f\"  Author: {event.author}\")\n        print(f\"\\n Compacted information: {event}\")\n        found_summary = True\n        break\n\nif not found_summary:\n    print(\n        \"\\nâŒ No compaction event found. Try increasing the number of turns in the demo.\"\n    )","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T13:02:58.969239Z","iopub.execute_input":"2025-11-14T13:02:58.969623Z","iopub.status.idle":"2025-11-14T13:02:58.981740Z","shell.execute_reply.started":"2025-11-14T13:02:58.969598Z","shell.execute_reply":"2025-11-14T13:02:58.980783Z"}},"outputs":[{"name":"stdout","text":"--- Searching for Compaction Summary Event ---\n\nâœ… SUCCESS! Found the Compaction Event:\n  Author: user\n\n Compacted information: model_version=None content=None grounding_metadata=None partial=None turn_complete=None finish_reason=None error_code=None error_message=None interrupted=None custom_metadata=None usage_metadata=None live_session_resumption_update=None input_transcription=None output_transcription=None avg_logprobs=None logprobs_result=None cache_metadata=None citation_metadata=None invocation_id='50645f2b-eb17-4a62-a4c4-2556dfc43129' author='user' actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction={'start_timestamp': 1763125262.523264, 'end_timestamp': 1763125270.393103, 'compacted_content': {'parts': [{'function_call': None, 'code_execution_result': None, 'executable_code': None, 'file_data': None, 'function_response': None, 'inline_data': None, 'text': 'The user inquired about the latest news in AI in healthcare. The AI agent provided a comprehensive overview of key trends, including diagnostics and imaging, AI-powered tools (like diagnostic support, robotic surgery, virtual assistants, and administrative tools), and emerging challenges such as data privacy, regulatory approval, ethics, integration, and explainability. The agent also highlighted recent developments like generative AI in healthcare, AI for rare diseases, and a focus on underserved populations, recommending reputable sources for further information.\\n\\nThe user then asked for more details on new developments in drug discovery. The AI agent elaborated on several key advancements:\\n1.  **Generative AI for Molecule Design:** AI can now design entirely new molecules with desired properties.\\n2.  **Accelerating Target Identification and Validation:** AI integrates multi-omics data to find disease targets and predict their druggability.\\n3.  **Improving Preclinical Testing:** AI is used for in silico screening, predicting clinical trial success, and potentially reducing animal testing.\\n4.  **Repurposing Existing Drugs:** AI aids in network pharmacology to find existing drugs for new diseases.\\n5.  **Enhancing Clinical Trial Design and Execution:** AI assists in patient stratification, biomarker discovery, and trial optimization.\\n\\nThe agent also listed key players in AI drug discovery and mentioned the underlying AI technologies.\\n\\nFinally, the user asked for more information about the \"Accelerated Drug Discovery\" development. The AI agent provided a detailed explanation of how AI speeds up the entire drug development pipeline. This included:\\n*   **Target Identification and Validation:** AI analyzes large datasets, predicts target druggability, and uncovers complex disease mechanisms.\\n*   **Hit Identification and Lead Optimization:** AI performs virtual screening, enables generative AI for de novo design, predicts molecular properties, and models structure-activity relationships.\\n*   **Preclinical and Clinical Development:** AI predicts ADMET properties, discovers biomarkers, optimizes clinical trial design, and assists in patient recruitment, ultimately aiming to reduce time, improve accuracy, expand the search space, and focus resources on promising candidates.\\n\\n**Unresolved Questions/Tasks:**\\n*   None. The conversation was informative and addressed the user\\'s queries.', 'thought': None, 'thought_signature': None, 'video_metadata': None}], 'role': 'model'}}, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None) long_running_tool_ids=set() branch=None id='619edf1d-423a-4226-bcc0-6b62f20c439c' timestamp=1763125276.941881\n","output_type":"stream"}],"execution_count":15},{"cell_type":"code","source":"# Define scope levels for state keys (following best practices)\nUSER_NAME_SCOPE_LEVELS = (\"temp\", \"user\", \"app\")\n\n\n# This demonstrates how tools can write to session state using tool_context.\n# The 'user:' prefix indicates this is user-specific data.\ndef save_userinfo(\n    tool_context: ToolContext, user_name: str, country: str\n) -> Dict[str, Any]:\n    \"\"\"\n    Tool to record and save user name and country in session state.\n\n    Args:\n        user_name: The username to store in session state\n        country: The name of the user's country\n    \"\"\"\n    # Write to session state using the 'user:' prefix for user data\n    tool_context.state[\"user:name\"] = user_name\n    tool_context.state[\"user:country\"] = country\n\n    return {\"status\": \"success\"}\n\n\n# This demonstrates how tools can read from session state.\ndef retrieve_userinfo(tool_context: ToolContext) -> Dict[str, Any]:\n    \"\"\"\n    Tool to retrieve user name and country from session state.\n    \"\"\"\n    # Read from session state\n    user_name = tool_context.state.get(\"user:name\", \"Username not found\")\n    country = tool_context.state.get(\"user:country\", \"Country not found\")\n\n    return {\"status\": \"success\", \"user_name\": user_name, \"country\": country}\n\n\nprint(\"âœ… Tools created.\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T13:03:49.239242Z","iopub.execute_input":"2025-11-14T13:03:49.239615Z","iopub.status.idle":"2025-11-14T13:03:49.247182Z","shell.execute_reply.started":"2025-11-14T13:03:49.239592Z","shell.execute_reply":"2025-11-14T13:03:49.246260Z"}},"outputs":[{"name":"stdout","text":"âœ… Tools created.\n","output_type":"stream"}],"execution_count":16},{"cell_type":"code","source":"# Configuration\nAPP_NAME = \"default\"\nUSER_ID = \"default\"\nMODEL_NAME = \"gemini-2.5-flash-lite\"\n\n# Create an agent with session state tools\nroot_agent = LlmAgent(\n    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n    name=\"text_chat_bot\",\n    description=\"\"\"A text chatbot.\n    Tools for managing user context:\n    * To record username and country when provided use `save_userinfo` tool. \n    * To fetch username and country when required use `retrieve_userinfo` tool.\n    \"\"\",\n    tools=[save_userinfo, retrieve_userinfo],  # Provide the tools to the agent\n)\n\n# Set up session service and runner\nsession_service = InMemorySessionService()\nrunner = Runner(agent=root_agent, session_service=session_service, app_name=\"default\")\n\nprint(\"âœ… Agent with session state tools initialized!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T13:04:04.706928Z","iopub.execute_input":"2025-11-14T13:04:04.707256Z","iopub.status.idle":"2025-11-14T13:04:04.714851Z","shell.execute_reply.started":"2025-11-14T13:04:04.707231Z","shell.execute_reply":"2025-11-14T13:04:04.713933Z"}},"outputs":[{"name":"stdout","text":"âœ… Agent with session state tools initialized!\n","output_type":"stream"}],"execution_count":17},{"cell_type":"code","source":"# Test conversation demonstrating session state\nawait run_session(\n    runner,\n    [\n        \"Hi there, how are you doing today? What is my name?\",  # Agent shouldn't know the name yet\n        \"My name is Sam. I'm from Poland.\",  # Provide name - agent should save it\n        \"What is my name? Which country am I from?\",  # Agent should recall from session state\n    ],\n    \"state-demo-session\",\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T13:05:09.783019Z","iopub.execute_input":"2025-11-14T13:05:09.783379Z","iopub.status.idle":"2025-11-14T13:05:12.434382Z","shell.execute_reply.started":"2025-11-14T13:05:09.783355Z","shell.execute_reply":"2025-11-14T13:05:12.433467Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: state-demo-session\n\nUser > Hi there, how are you doing today? What is my name?\ngemini-2.5-flash-lite >  Hello! I'm doing great, thank you for asking. I don't have access to your name yet. If you'd like to tell me your name, I can remember it for you.\n\nUser > My name is Sam. I'm from Poland.\n","output_type":"stream"},{"name":"stderr","text":"WARNING:google_genai.types:Warning: there are non-text parts in the response: ['function_call'], returning concatenated text result from text parts. Check the full candidates.content.parts accessor to get the full model response.\n","output_type":"stream"},{"name":"stdout","text":"gemini-2.5-flash-lite >  It is a pleasure to meet you, Sam! I have saved your name and country. How else may I help you today?\n\nUser > What is my name? Which country am I from?\n","output_type":"stream"},{"name":"stderr","text":"WARNING:google_genai.types:Warning: there are non-text parts in the response: ['function_call'], returning concatenated text result from text parts. Check the full candidates.content.parts accessor to get the full model response.\n","output_type":"stream"},{"name":"stdout","text":"gemini-2.5-flash-lite >  Your name is Sam and you are from Poland.\n","output_type":"stream"}],"execution_count":18},{"cell_type":"code","source":"# Retrieve the session and inspect its state\nsession = await session_service.get_session(\n    app_name=APP_NAME, user_id=USER_ID, session_id=\"state-demo-session\"\n)\n\nprint(\"Session State Contents:\")\nprint(session.state)\nprint(\"\\nðŸ” Notice the 'user:name' and 'user:country' keys storing our data!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T13:05:32.633535Z","iopub.execute_input":"2025-11-14T13:05:32.634650Z","iopub.status.idle":"2025-11-14T13:05:32.640951Z","shell.execute_reply.started":"2025-11-14T13:05:32.634617Z","shell.execute_reply":"2025-11-14T13:05:32.640088Z"}},"outputs":[{"name":"stdout","text":"Session State Contents:\n{'user:name': 'Sam', 'user:country': 'Poland'}\n\nðŸ” Notice the 'user:name' and 'user:country' keys storing our data!\n","output_type":"stream"}],"execution_count":19},{"cell_type":"code","source":"# Start a completely new session - the agent won't know our name\nawait run_session(\n    runner,\n    [\"Hi there, how are you doing today? What is my name?\"],\n    \"new-isolated-session\",\n)\n\n# Expected: The agent won't know the name because this is a different session","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T13:05:47.883568Z","iopub.execute_input":"2025-11-14T13:05:47.884022Z","iopub.status.idle":"2025-11-14T13:05:48.536496Z","shell.execute_reply.started":"2025-11-14T13:05:47.883995Z","shell.execute_reply":"2025-11-14T13:05:48.535582Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: new-isolated-session\n\nUser > Hi there, how are you doing today? What is my name?\ngemini-2.5-flash-lite >  Hello! I'm doing great. I can't recall your name just yet, but I'd be happy to remember it if you tell me!\n","output_type":"stream"}],"execution_count":20},{"cell_type":"code","source":"# Check the state of the new session\nsession = await session_service.get_session(\n    app_name=APP_NAME, user_id=USER_ID, session_id=\"new-isolated-session\"\n)\n\nprint(\"New Session State:\")\nprint(session.state)\n\n# Note: Depending on implementation, you might see shared state here.\n# This is where the distinction between session-specific and user-specific state becomes important.","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T13:06:19.272386Z","iopub.execute_input":"2025-11-14T13:06:19.272687Z","iopub.status.idle":"2025-11-14T13:06:19.278746Z","shell.execute_reply.started":"2025-11-14T13:06:19.272664Z","shell.execute_reply":"2025-11-14T13:06:19.277818Z"}},"outputs":[{"name":"stdout","text":"New Session State:\n{'user:name': 'Sam', 'user:country': 'Poland'}\n","output_type":"stream"}],"execution_count":21},{"cell_type":"code","source":"# Clean up any existing database to start fresh (if Notebook is restarted)\nimport os\n\nif os.path.exists(\"my_agent_data.db\"):\n    os.remove(\"my_agent_data.db\")\nprint(\"âœ… Cleaned up old database files\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T13:06:31.536347Z","iopub.execute_input":"2025-11-14T13:06:31.537347Z","iopub.status.idle":"2025-11-14T13:06:31.544810Z","shell.execute_reply.started":"2025-11-14T13:06:31.537317Z","shell.execute_reply":"2025-11-14T13:06:31.543638Z"}},"outputs":[{"name":"stdout","text":"âœ… Cleaned up old database files\n","output_type":"stream"}],"execution_count":22}]}